发明申请
- 专利标题： Novel tyrosine kinase inhibitors
- 专利标题（中）： 新型酪氨酸激酶抑制剂
-
申请号： US11289834申请日： 2005-11-30
-
公开(公告)号： US20060079518A1公开(公告)日： 2006-04-13
- 发明人: Mark Wittman , Neelakantan Balasubramanian , Upender Velaparthi , Kurt Zimmermann , Mark Saulnier , Peiying Liu , Xiaopeng Sang , David Frennesson , Karen Stoffan , James Tarrant , Anne Marinier , Stephan Roy
- 申请人： Mark Wittman , Neelakantan Balasubramanian , Upender Velaparthi , Kurt Zimmermann , Mark Saulnier , Peiying Liu , Xiaopeng Sang , David Frennesson , Karen Stoffan , James Tarrant , Anne Marinier , Stephan Roy
- 主分类号： A61K31/54
- IPC分类号： A61K31/54 ; A61K31/535 ; A61K31/513
摘要：
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.
公开/授权文献
- US07223757B2 Tyrosine kinase inhibitors 公开/授权日：2007-05-29
信息查询
